The Mepilex Cesarean Delivery Trial / MEPIDEL
NCT07914569
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn whether a silver-containing foam dressing (Mepilex Border Post-Op Ag) works as well as the standard dressing in preventing surgical site infection after cesarean delivery. The main questions it aims to answer are: Is the rate of surgical site infection with Mepilex Border Post-Op Ag no worse than with the standard dressing? How do the two dressings compare for other wound problems, wound-related hospital or clinic visits, and patient satisfaction?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Surgical Site Infection
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Montefiore Medical Center
- Last updated on ClinicalTrials.gov
- November 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Montefiore-Einstein Jack D. Weiler Hospital · The Bronx, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.